Log in

NASDAQ:RMTIRockwell Medical Stock Price, Forecast & News

+0.04 (+2.45 %)
(As of 08/14/2020 04:00 PM ET)
Today's Range
Now: $1.67
50-Day Range
MA: $1.84
52-Week Range
Now: $1.67
Volume599,075 shs
Average Volume932,664 shs
Market Capitalization$117.40 million
P/E RatioN/A
Dividend YieldN/A
Rockwell Medical, Inc. operates as a specialty pharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis. It is also developing an intravenous formulation of Triferic for use by hemodialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. Its target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1994 and is based in Wixom, Michigan.
Read More
Rockwell Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.91 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryHealth Care Equipment
Current SymbolNASDAQ:RMTI



Sales & Book Value

Annual Sales$61.30 million
Book Value$0.32 per share


Net Income$-34,130,000.00


Market Cap$117.40 million
Next Earnings Date11/9/2020 (Estimated)
+0.04 (+2.45 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions

How has Rockwell Medical's stock price been impacted by Coronavirus (COVID-19)?

Rockwell Medical's stock was trading at $2.88 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RMTI stock has decreased by 42.0% and is now trading at $1.67.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Rockwell Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Rockwell Medical

When is Rockwell Medical's next earnings date?

Rockwell Medical is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020.
View our earnings forecast for Rockwell Medical

How were Rockwell Medical's earnings last quarter?

Rockwell Medical Inc (NASDAQ:RMTI) announced its earnings results on Monday, August, 10th. The company reported ($0.10) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.14) by $0.04. Rockwell Medical had a negative net margin of 54.27% and a negative return on equity of 140.20%.
View Rockwell Medical's earnings history

What guidance has Rockwell Medical issued on next quarter's earnings?

Rockwell Medical issued an update on its second quarter 2020 After-Hours earnings guidance on Monday, July, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $15.4-15.8 million, compared to the consensus revenue estimate of $13.51 million.

What price target have analysts set for RMTI?

2 Wall Street analysts have issued twelve-month price objectives for Rockwell Medical's shares. Their forecasts range from $6.00 to $9.00. On average, they expect Rockwell Medical's share price to reach $7.50 in the next twelve months. This suggests a possible upside of 349.1% from the stock's current price.
View analysts' price targets for Rockwell Medical

Has Rockwell Medical been receiving favorable news coverage?

Press coverage about RMTI stock has trended very positive on Saturday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Rockwell Medical earned a news sentiment score of 4.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days.
View the latest news about Rockwell Medical

Are investors shorting Rockwell Medical?

Rockwell Medical saw a increase in short interest in June. As of June 30th, there was short interest totaling 5,730,000 shares, an increase of 29.9% from the June 15th total of 4,410,000 shares. Based on an average daily volume of 618,400 shares, the days-to-cover ratio is presently 9.3 days. Currently, 9.4% of the company's shares are sold short.
View Rockwell Medical's Short Interest

Who are some of Rockwell Medical's key competitors?

What other stocks do shareholders of Rockwell Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seattle Genetics (SGEN), Opko Health (OPK), Geron (GERN), Amarin (AMRN), Eyepoint Pharmaceuticals (EYPT), Gilead Sciences (GILD), Heron Therapeutics (HRTX) and Iovance Biotherapeutics (IOVA).

Who are Rockwell Medical's key executives?

Rockwell Medical's management team includes the following people:
  • Mr. Stuart Paul, Pres, CEO & Director (Age 59)
  • Mr. Angus W. Smith, Chief Financial Officer (Age 36)
  • Dr. Ajay Gupta, Chief Scientific Officer & Member of Scientific Advisory Board (Age 61)
  • Mr. Michael DeYoung, VP of Operations
  • Mr. David J. Kull, Principal Accounting Officer, Sec. & Controller (Age 51)

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

Who are Rockwell Medical's major shareholders?

Rockwell Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Bank of New York Mellon Corp (0.36%), SkyOak Wealth LLC (0.28%), California Public Employees Retirement System (0.20%), Sigma Investment Counselors Inc. (0.15%), OneAscent Financial Services LLC (0.04%) and Johnson Investment Counsel Inc. (0.04%). Company insiders that own Rockwell Medical stock include Angus W Smith, David S Richmond, Russell H Ellison and Stuart M Paul.
View institutional ownership trends for Rockwell Medical

Which major investors are selling Rockwell Medical stock?

RMTI stock was sold by a variety of institutional investors in the last quarter, including SkyOak Wealth LLC, and UBS Group AG.
View insider buying and selling activity for Rockwell Medical

Which major investors are buying Rockwell Medical stock?

RMTI stock was purchased by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, OneAscent Financial Services LLC, Johnson Investment Counsel Inc., Bank of New York Mellon Corp, Sigma Investment Counselors Inc., Prudential Financial Inc., Bank of America Corp DE, and Commonwealth Equity Services LLC. Company insiders that have bought Rockwell Medical stock in the last two years include Angus W Smith, David S Richmond, Russell H Ellison, and Stuart M Paul.
View insider buying and selling activity for Rockwell Medical

How do I buy shares of Rockwell Medical?

Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Rockwell Medical's stock price today?

One share of RMTI stock can currently be purchased for approximately $1.67.

How big of a company is Rockwell Medical?

Rockwell Medical has a market capitalization of $117.40 million and generates $61.30 million in revenue each year. The company earns $-34,130,000.00 in net income (profit) each year or ($0.56) on an earnings per share basis. Rockwell Medical employs 269 workers across the globe.

What is Rockwell Medical's official website?

The official website for Rockwell Medical is www.rockwellmed.com.

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 411 HACKENSACK AVENUE SUITE 501, HACKENSACK NJ, 07601. The company can be reached via phone at 248-960-9009 or via email at [email protected]

This page was last updated on 8/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.